Professor He Ruyi, M.D.
- Chief Medical Officer, RemeGen
Dr. Ruyi He is the Chief Medical Officer of RemeGen CO., Ltd. and Chief Scientist of SDIC Fund Management CO., LTD and former Chief Scientist at the Center for Drug Evaluation at the National Medical Products Administration (NMPA). Dr. He joined NMPA in July 2016, after having worked at the US Food and Drug Administration (FDA) for more than 17 years. Dr. He joined the US Center for Drug Evaluation and Research (CDER) at the US FDA in 1999 as a Medical Officer in the Division of Gastrointestinal and Coagulation Drug Products and later served as the Acting Deputy Director in the division for years. Dr. He received his medical degree from China Medical University. He completed his intern and residency training in Internal Medicine at Howard University Hospital in Washington, DC. and received his clinical and research training at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH) in Bethesda, Maryland. Dr. He is a licensed, board-certified physician in Internal Medicine in the USA.